|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
US4863457A
(en)
|
1986-11-24 |
1989-09-05 |
Lee David A |
Drug delivery device
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
ES2113094T3
(es)
|
1993-03-09 |
1998-04-16 |
Epic Therapeutics Inc |
Las microparticulas macromoleculares y metodos de obtencion.
|
|
US5603960A
(en)
|
1993-05-25 |
1997-02-18 |
O'hagan; Derek T. |
Preparation of microparticles and method of immunization
|
|
ATE251886T1
(de)
|
1993-08-31 |
2003-11-15 |
Univ Duke |
Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
|
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
AU720446B2
(en)
|
1995-11-01 |
2000-06-01 |
Kos Pharmaceuticals, Incorporated |
Apolipoprotein E2 and treatment of Alzheimer's disease
|
|
EP0930874A2
(en)
|
1996-10-09 |
1999-07-28 |
Takeda Chemical Industries, Ltd. |
A method for producing a microparticle
|
|
US6210707B1
(en)
|
1996-11-12 |
2001-04-03 |
The Regents Of The University Of California |
Methods of forming protein-linked lipidic microparticles, and compositions thereof
|
|
US6884435B1
(en)
|
1997-01-30 |
2005-04-26 |
Chiron Corporation |
Microparticles with adsorbent surfaces, methods of making same, and uses thereof
|
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
EP1121429A2
(en)
|
1998-10-16 |
2001-08-08 |
Introgene B.V. |
Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e
|
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
|
EP1670517A1
(en)
|
2003-09-26 |
2006-06-21 |
Eli Lilly And Company |
Lentiviral apoe2 gene therapy
|
|
WO2005116204A1
(ja)
|
2004-05-11 |
2005-12-08 |
Rnai Co., Ltd. |
Ｒｎａ干渉を生じさせるポリヌクレオチド、および、これを用いた遺伝子発現抑制方法
|
|
US7687616B1
(en)
|
2004-05-14 |
2010-03-30 |
Rosetta Genomics Ltd |
Small molecules modulating activity of micro RNA oligonucleotides and micro RNA targets and uses thereof
|
|
US20070081972A1
(en)
|
2005-09-30 |
2007-04-12 |
The University Of Iowa Research Foundation |
Polymer-based delivery system for immunotherapy of cancer
|
|
US20070248599A1
(en)
|
2006-02-21 |
2007-10-25 |
Jordan Tang |
Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
|
|
EP2114153B1
(en)
|
2007-02-06 |
2016-11-23 |
Tai June Yoo |
Treatment and prevention of neurodegenerative diseases using gene therapy
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
WO2012054425A2
(en)
|
2010-10-18 |
2012-04-26 |
University Of Iowa Research Foundation |
Biodegradable particulate formulations
|
|
JP2014511174A
(ja)
|
2011-02-07 |
2014-05-15 |
ネオトープ バイオサイエンシーズ リミテッド |
Ａｐｏｅ免疫療法
|
|
US9345776B2
(en)
|
2011-02-24 |
2016-05-24 |
The University Of Iowa Research Foundation |
Biodegradable polymers with sulfenamide bonds for drug delivery applications
|
|
CN104540952A
(zh)
|
2012-05-18 |
2015-04-22 |
衣阿华大学研究基金会 |
用于治疗淀粉状蛋白沉积的方法和组合物
|
|
WO2013181618A2
(en)
|
2012-05-31 |
2013-12-05 |
The Trustees Of Columbia University In The City Of New York |
Methods to treat alzheimer's disease using apoe inhibitors
|
|
WO2015013363A2
(en)
|
2013-07-24 |
2015-01-29 |
The General Hospital Corporation |
Agents and methods for inhibiting mir-148a for the modulation of cholesterol levels
|
|
IL245703B
(en)
|
2013-11-20 |
2022-07-01 |
Univ Iowa Res Found |
Methods and compositions for treating amyloid deposits
|
|
CN107073051B
(zh)
|
2014-10-21 |
2021-08-24 |
马萨诸塞大学 |
重组aav变体及其用途
|
|
EP3452074A4
(en)
|
2016-05-03 |
2019-12-11 |
University of South Florida |
COMPOSITIONS AND METHOD FOR MODULATING THE ABETA PROTEIN
|
|
JP7610923B2
(ja)
|
2016-09-02 |
2025-01-09 |
スパーク セラピューティクス インコーポレイテッド |
Ｃｎｓ障害を治療するための方法及びベクター
|
|
CN106890315B
(zh)
|
2017-03-16 |
2019-09-06 |
北京热休生物技术有限公司 |
Apo-e蛋白及其多肽在治疗与预防癌症中的应用
|
|
WO2018178994A1
(en)
|
2017-03-29 |
2018-10-04 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods specifically targeting the apolipoprotein e4 (apoe4) and uses thereof in apoe4 associated conditions
|
|
US11680275B2
(en)
|
2017-06-06 |
2023-06-20 |
University Of Massachusetts |
Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome
|
|
WO2018226887A1
(en)
|
2017-06-07 |
2018-12-13 |
Spark Therapeutics, Inc. |
ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION
|
|
EP3808849A1
(en)
*
|
2017-08-03 |
2021-04-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
AU2018338728B2
(en)
|
2017-09-29 |
2025-01-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery
|
|
US11071791B2
(en)
|
2018-01-26 |
2021-07-27 |
Wisconsin Alumni Research Foundation |
Vector for gene silencing and replacement and methods of use thereof
|
|
WO2019217483A1
(en)
|
2018-05-07 |
2019-11-14 |
Spark Therapeutics, Inc. |
Plasmid free aav vector producing cell lines
|
|
WO2019222329A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
US20210371470A1
(en)
|
2018-10-12 |
2021-12-02 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
JP7616995B2
(ja)
|
2018-11-28 |
2025-01-17 |
プリベイル セラピューティクス，インコーポレーテッド |
神経変性疾患のための遺伝子治療
|
|
CN109776665B
(zh)
|
2019-02-02 |
2021-02-05 |
首都医科大学宣武医院 |
阿尔茨海默病新突变、其稳转细胞模型及医药用途
|
|
CN113811311A
(zh)
|
2019-03-15 |
2021-12-17 |
马萨诸塞大学 |
用于组织特异性apoe调节的寡核苷酸
|
|
AU2020282792B2
(en)
|
2019-05-28 |
2025-12-04 |
Banner Health |
ApoE antibodies, fusion proteins and uses thereof
|
|
JP2023500793A
(ja)
|
2019-10-16 |
2023-01-11 |
コーネル・ユニバーシティー |
アルツハイマー病に対する遺伝子治療方法
|
|
EP4065600A1
(en)
|
2019-11-25 |
2022-10-05 |
Cornell University |
Apoe gene therapy
|
|
JP7539723B2
(ja)
|
2020-02-21 |
2024-08-26 |
コンバインド セラピューティクス インコーポレイテッド |
コード化リボ核酸の器官保護発現及び調節のための組成物並びに方法
|
|
CN111471716B
(zh)
|
2020-05-20 |
2021-10-15 |
上海市同济医院 |
一种基于重组腺相关病毒8型的microRNA-212-3P海绵的构建及其应用
|
|
CN114250235A
(zh)
|
2020-09-21 |
2022-03-29 |
华东理工大学 |
一种重组腺相关病毒载体疫苗的设计方法及应用
|
|
KR20230112672A
(ko)
|
2020-11-25 |
2023-07-27 |
프리베일 테라퓨틱스, 인크. |
신경변성 질환을 위한 유전자 요법
|
|
EP4334446A1
(en)
|
2021-05-03 |
2024-03-13 |
CureVac SE |
Improved nucleic acid sequence for cell type specific expression
|
|
JP2025513066A
(ja)
|
2022-04-12 |
2025-04-22 |
ユニキュアー バイオファーマ ビー．ブイ． |
Ａｐｏｅの核酸制御
|
|
IL316236A
(en)
|
2022-04-15 |
2024-12-01 |
Encoded Therapeutics Inc |
Elements for removing gene expression targeting in the liver
|
|
EP4551711A1
(en)
|
2022-07-08 |
2025-05-14 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of alzheimers disease
|
|
CN116574760A
(zh)
|
2023-04-13 |
2023-08-11 |
中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） |
一种基于miR-302d骨架的高效率shRNA表达载体及其制备和应用
|
|
CN121335984A
(zh)
|
2023-04-18 |
2026-01-13 |
康奈尔大学 |
用于治疗和预防阿尔茨海默病的方法和apoe药物组合物
|
|
WO2024220722A1
(en)
|
2023-04-18 |
2024-10-24 |
Cornell University |
Compositions and methods for tissue- specific expression of gene therapies
|
|
WO2025213111A2
(en)
|
2024-04-05 |
2025-10-09 |
Cornell University |
Aav expression of mirna to suppress human apoe mrna
|